Для наиболее комфортного просмотра сайта, включите, пожалуйста, JavaScript в настройках браузера

Evidence
base

How to prevent chronicization of back pain: the role of chondroprotectors

O.S. Levin

Experience of application of Alflutop in treatment of professional vertebrogenic pathology

E.Yu. Radoutskaya, I.I. Novikova, Y.V. Erofeev

Multicenter blind randomized placebo-controlled study of symptom- and structure-modifying effect of the drug Alflutop in patients with osteoarthritis of knee joints. Report 1 - evaluation of symptom-modifying effect of the drug

V.A. Shirokov

Long-term therapy with Alflutop: effect on symptoms and quality of life in patients with early-stage gonarthrosis (5-year follow-up)

M.S. Svetlova

Evaluation of therapeutic efficacy of Alflutop in the complex treatment of patients with chronic low back pain (observational study CEITNOT)

I.N. Samartsev, S.A. Zhivolupov, E.R. Barantsevich, A.B. Danilov

Effectiveness of Alflutop in chronic vertebrogenic lumboischialgia according to the data of double-blind placebo-controlled study

O. S. Levin, D.Yu. S. Levin, D.Y. Olyunin, L.V. Golubeva

Quantitative assessment and analysis of central mechanisms of analgesic effect of Alflutop in patients with chronic low back pain

S.A. Zhivolupov, I.N. Samartsev , V.V. Ponomarev

Evaluation of efficacy and safety of combined therapy with symptomatic delayed-acting drug and hyaluronic acid in comparison with hyaluronic acid monotherapy in patients with osteoarthritis of the knee joint

Berdyugin K.A., Kadyntsev I.V., Berdyugina O.V., Taskina  E.A., Kashevarova N.G.